Literature DB >> 19491063

Anaplastic thyroid cancer manifesting as new-onset Horner syndrome.

James T Broome1, Paul G Gauger, Barbra S Miller, Gerard M Doherty.   

Abstract

OBJECTIVE: To report a case of Horner syndrome as the initial sign of locally advanced anaplastic thyroid cancer.
METHODS: We present a case report in conjunction with a retrospective review and evaluation of the English-language literature on Horner syndrome and thyroid pathologic conditions.
RESULTS: Horner syndrome is a rare complication of thyroid disease most often occurring in the postoperative setting after resections. Preoperatively, Horner syndrome is usually caused by a benign intrathoracic goiter that compresses the sympathetic plexus as it exits the thoracic cavity to enter the neck. Malignant thyroid disease leading to Horner syndrome is less common than benign causes of the syndrome. Treatment of compressive lesions can lead to resolution of nerve compression.
CONCLUSION: Horner syndrome is a rare complication of thyroid pathologic conditions. When present preoperatively, the majority of cases are due to benign compression of the cervical plexus. Therefore, Horner syndrome in the setting of a goiter does not necessarily portend a malignant process as one might suspect. Nonetheless, it still remains important that those patients who present with Horner syndrome undergo appropriate assessment for detection of mass lesions, underlying vascular etiologic factors, or other potentially treatable disorders causing sympathetic chain dysfunction.

Entities:  

Mesh:

Year:  2009        PMID: 19491063     DOI: 10.4158/EP09106.CRR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  5 in total

1.  Horner's syndrome following a subtotal thyroidectomy for a benign nodular goitre.

Authors:  Murat Aslankurt; Lokman Aslan; Mustafa Colak; Adnan Aksoy
Journal:  BMJ Case Rep       Date:  2013-06-13

2.  Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E).

Authors:  Amjad Husain; Nina Hu; Peter M Sadow; Carmelo Nucera
Journal:  Cancer Lett       Date:  2015-07-17       Impact factor: 8.679

3.  Brain Metastases of Papillary Thyroid Carcinoma with Horner's Syndrome.

Authors:  Sung-Hoon Cho; Sang-Hyo Kim; Jung-Hwan Lee; Won-Il Joo; Chung-Kee Chough; Hae-Kwan Park; Kyung-Jin Lee; Hyoung-Kyun Rha
Journal:  Brain Tumor Res Treat       Date:  2014-10-31

4.  Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer.

Authors:  Matthew A Nehs; Carmelo Nucera; Sushruta S Nagarkatti; Peter M Sadow; Dieter Morales-Garcia; Richard A Hodin; Sareh Parangi
Journal:  Endocrinology       Date:  2011-12-27       Impact factor: 4.736

Review 5.  Horner syndrome after thyroid-related surgery: a review.

Authors:  Hongdan Chen; Fan Zhang; Mi Tang; Supeng Yin; Zeyu Yang; Yiceng Sun
Journal:  Langenbecks Arch Surg       Date:  2022-08-10       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.